BMS-830216 Uses, Dosage, Side Effects and more
BMS-830216 is under investigation in clinical trial NCT00909766 (Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects).
| Trade Name | BMS-830216 |
| Generic | BMS-830216 |
| Type | |
| Formula | C24H22ClN2O7PS |
| Weight | Average: 548.93 Monoisotopic: 548.0573869 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
